302 related articles for article (PubMed ID: 26830367)
1. The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy.
Kim SE; Lee JH; Chae MK; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):301-11. PubMed ID: 26830367
[TBL] [Abstract][Full Text] [Related]
2. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy.
Ko J; Chae MK; Lee JH; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2544-2553. PubMed ID: 28492873
[TBL] [Abstract][Full Text] [Related]
4. Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
Ko J; Kim JY; Kim JW; Yoon JS
Endocr J; 2020 Apr; 67(4):439-447. PubMed ID: 31941844
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoke extract-induced adipogenesis in Graves' orbital fibroblasts is inhibited by quercetin via reduction in oxidative stress.
Yoon JS; Lee HJ; Chae MK; Lee SY; Lee EJ
J Endocrinol; 2013 Feb; 216(2):145-56. PubMed ID: 23143154
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
Ko J; Kim JY; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy.
Kim BR; Kim J; Lee JE; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):39. PubMed ID: 32196098
[TBL] [Abstract][Full Text] [Related]
8. PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis.
Ko J; Kim JY; Kyoung Chae M; Jig Lee E; Sook Yoon J
J Mol Endocrinol; 2021 May; 66(4):313-323. PubMed ID: 33870911
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy.
Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
PLoS One; 2019; 14(8):e0221077. PubMed ID: 31415657
[TBL] [Abstract][Full Text] [Related]
10. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate is involved in inflammatory reactions in patients with Graves' orbitopathy.
Seo Y; Chae MK; Han SA; Lee EJ; Lee JH; Yoon JS
Inflamm Res; 2017 Jun; 66(6):535-545. PubMed ID: 28364200
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Effect of Resveratrol on Oxidative Stress in Graves' Orbitopathy Orbital Fibroblasts.
Kim CY; Lee HJ; Chae MK; Byun JW; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6352-61. PubMed ID: 26436888
[TBL] [Abstract][Full Text] [Related]
13. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the expression of sphingosine 1-phosphate 2 receptors regulates the differentiation of pre-adipocytes.
Jeong JK; Moon MH; Park SY
Mol Med Rep; 2015 Nov; 12(5):7496-502. PubMed ID: 26459774
[TBL] [Abstract][Full Text] [Related]
15. Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
Lee JS; Chae MK; Kikkawa DO; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):51. PubMed ID: 32735324
[TBL] [Abstract][Full Text] [Related]
16. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Mulder MT; Hirankarn N; van Hagen PM; Dik WA
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5457-64. PubMed ID: 26284551
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Effect of Protocatechuic Aldehyde in an In Vitro Model of Graves' Orbitopathy.
Byun JW; Hwang S; Kang CW; Kim JH; Chae MK; Yoon JS; Lee EJ
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4055-62. PubMed ID: 27494347
[TBL] [Abstract][Full Text] [Related]
18. CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' Orbitopathy.
Plöhn S; Edelmann B; Japtok L; He X; Hose M; Hansen W; Schuchman EH; Eckstein A; Berchner-Pfannschmidt U
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5391-5397. PubMed ID: 30452592
[TBL] [Abstract][Full Text] [Related]
19. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effect of Curcumin, a Plant Polyphenol Extracted From Curcuma longae, in Fibroblasts From Patients With Graves' Orbitopathy.
Lee JS; Kim J; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4129-4140. PubMed ID: 31593984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]